Skip to main content

Table 1 Correlation of tumor MTSS1 mRNA expression level with clinicopathological parameters of HCC patients

From: Elevated MTSS1 expression associated with metastasis and poor prognosis of residual hepatitis B-related hepatocellular carcinoma

Clinicopathological parameters

Number

MTSS1/GAPDH mRNA (n)

P

MTSS1-low group

MTSS1-high group

(≤0.18, n = 17)

(>0.18, n = 20)

Age

37

  

0.900

  ≤ 52 y

20

9

11

 

  > 52 y

17

8

9

 

Sex

37

  

0.588

 Female

8

3

5

 

 Male

29

14

15

 

Cirrhosis

37

  

0.855

 Yes

30

14

16

 

 No

7

3

4

 

Tumor number

37

  

0.035*

 Multiple

20

6

14

 

 Single

17

11

6

 

Satellite

36a

  

0.019*

 Yes

15

3

12

 

 No

21

13

8

 

Tumor size, cm

37

  

0.212

  ≤ 5

7

5

2

 

  > 5

30

12

18

 

Encapsulation

37

  

0.008**

 Complete

15

11

4

 

 Incomplete or none

22

6

16

 

Vascular invasion

36a

  

0.042*

 Yes

21

6

15

 

 No

15

11

4

 

TNM stage

37

  

0.033*

 Early stage (II)

7

6

1

 

 Advanced stage (III-IVA)

30

11

19

 

AFP level, ng/mL

37

  

0.036*

  ≤ 20

11

2

9

 

  > 20

26

15

11

 

γ-Glutamyl transferase, units/L

37

  

0.134

  ≤ 54

19

11

8

 

  > 54

18

6

12

 

Adjuvant TACE

37

  

0.815

 Yes

16

7

9

 

 No

21

10

11

 
  1. NOTE: HCC hepatocellular carcinoma, TACE transcatheter arterial chemoembolization
  2. Significant difference: * < 0.05, ** < 0.01
  3. aNumber less than 37 due to missing data